![Ronald McCaughan](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Ronald McCaughan
Chief Executive Officer at Noninvasive Medical Technologies, Inc.
Profile
Ronald McCaughan is currently the Chairman & Chief Executive Officer at Noninvasive Medical Technologies, Inc.
Known holdings in public companies
Company | Date | Number of shares | Valuation | Valuation date |
---|---|---|---|---|
Noninvasive Medical Technologies, Inc.
![]() Noninvasive Medical Technologies, Inc. Medical SpecialtiesHealth Technology Noninvasive Medical Technologies, Inc. manufactures medical devices. Its products include IQ2, an impedance cardiograph device that uses thoracic electrical bio impedance to monitor hemo dynamics, including the blood flow, cardiac output, cardiac index, stroke volume and heart rate, ZOE Fluid Status Monitor, NcIQ Casualty Management System and ETag. The company was founded in 2003 and is headquartered in Las Vegas, NV. inf% | 09/02/2007 | 1,190,476 ( inf% ) | - $ | Today |
Ronald McCaughan active positions
Companies | Position | Start |
---|---|---|
Noninvasive Medical Technologies, Inc.
![]() Noninvasive Medical Technologies, Inc. Medical SpecialtiesHealth Technology Noninvasive Medical Technologies, Inc. manufactures medical devices. Its products include IQ2, an impedance cardiograph device that uses thoracic electrical bio impedance to monitor hemo dynamics, including the blood flow, cardiac output, cardiac index, stroke volume and heart rate, ZOE Fluid Status Monitor, NcIQ Casualty Management System and ETag. The company was founded in 2003 and is headquartered in Las Vegas, NV. | Chief Executive Officer | - |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
Private companies | 1 |
---|---|
Noninvasive Medical Technologies, Inc.
![]() Noninvasive Medical Technologies, Inc. Medical SpecialtiesHealth Technology Noninvasive Medical Technologies, Inc. manufactures medical devices. Its products include IQ2, an impedance cardiograph device that uses thoracic electrical bio impedance to monitor hemo dynamics, including the blood flow, cardiac output, cardiac index, stroke volume and heart rate, ZOE Fluid Status Monitor, NcIQ Casualty Management System and ETag. The company was founded in 2003 and is headquartered in Las Vegas, NV. | Health Technology |
- Stock Market
- Insiders
- Ronald McCaughan